Reaction
Cystic Fibrosis Related Diabetes reporting signals
As of the last recalculation, Cystic Fibrosis Related Diabetes appears in 143 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR (PRR 1,205.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Elexacaftor, Tezacaftor, And Ivacaftor | 60 | 1,205.7 | 1,211.6 |
| Dornase Alfa | 32 | 305.7 | 306.2 |
| Ivacaftor | 12 | 239.9 | 240.3 |
| Tobramycin | 26 | 192.1 | 192.3 |
| Lumacaftor And Ivacaftor | 10 | 182.5 | 182.7 |
| Pancrelipase | 35 | 174.4 | 174.6 |
| Tobramycin Solution | 10 | 130.2 | 130.3 |
| Tobramycin Sulfate | 10 | 126.3 | 126.4 |